{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:30:52Z","timestamp":1792859452025,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Neurosciences Research at HealthPartners Institute for Education and Research"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.neulet.2014.11.013","type":"journal-article","created":{"date-parts":[[2014,11,16]],"date-time":"2014-11-16T18:39:07Z","timestamp":1416163147000},"page":"362-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP\/PS1 model of amyloid accumulation"],"prefix":"10.1016","volume":"584","author":[{"given":"Jared M.","family":"Fine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Forsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin T.","family":"Galick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6415-5034","authenticated-orcid":false,"given":"Benjamin M.","family":"Stroebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"William H.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah R.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2014.11.013_bib0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/B978-0-12-386986-9.00011-9","article-title":"Alzheimer\u2019s disease and amyloid: culprit or coincidence?","volume":"102","author":"Skaper","year":"2012","journal-title":"Int. Rev. Neurobiol."},{"issue":"6","key":"10.1016\/j.neulet.2014.11.013_bib0010","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1515\/revneuro-2013-0034","article-title":"New animal models of Alzheimer\u2019s disease that display insulin desensitization in the brain","volume":"24","author":"Gao","year":"2013","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neulet.2014.11.013_bib0015","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-130209","article-title":"Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer\u2019s disease detected in vivo with magnetic resonance imaging","author":"Raven","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neulet.2014.11.013_bib0020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2012.10.558","article-title":"Metallostasis in Alzheimer\u2019s disease","volume":"62","author":"Ayton","year":"2013","journal-title":"Free Radical Biol. Med."},{"issue":"7","key":"10.1016\/j.neulet.2014.11.013_bib0025","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.neurobiolaging.2007.02.006","article-title":"Reversion of age-related recognition memory impairment by iron chelation in rats","volume":"29","author":"de Lima","year":"2008","journal-title":"Neurobiol. Aging"},{"issue":"8753","key":"10.1016\/j.neulet.2014.11.013_bib0030","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-B","article-title":"Intramuscular desferrioxamine in patients with Alzheimer\u2019s disease","volume":"337","author":"Crapper McLachlan","year":"1991","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.neulet.2014.11.013_bib0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00221-012-3101-0","article-title":"Intranasal deferoxamine improves performance in radial arm water maze: stabilizes HIF-1alpha, and phosphorylates GSK3beta in P301L tau transgenic mice","volume":"219","author":"Fine","year":"2012","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neulet.2014.11.013_bib0040","first-page":"1","article-title":"Intranasal delivery of deferoxamine reduces spatial memory loss in APP\/PS1 mice","author":"Hanson","year":"2012","journal-title":"Drug Delivery Transl. Res."},{"key":"10.1016\/j.neulet.2014.11.013_bib0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.expneurol.2013.03.017","article-title":"Chronic intranasal deferoxamine ameliorates motor defects and pathology in the alpha-synuclein rAAV Parkinson\u2019s model","volume":"247C","author":"Febbraro","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2014.11.013_bib0050","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.brainres.2014.05.048","article-title":"Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinson\u2019s disease","volume":"1574","author":"Fine","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2014.11.013_bib0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2004.02.081","article-title":"Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer\u2019s disease: linkage of poorer cognitive performance to tau pathology in forebrain","volume":"1\u20132","author":"Arendash","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2014.11.013_bib0060","article-title":"Intranasal administration of CNS therapeutics to awake mice","volume":"74","author":"Hanson","year":"2013","journal-title":"J. Visualized Exp."},{"issue":"8","key":"10.1016\/j.neulet.2014.11.013_bib0065","doi-asserted-by":"crossref","first-page":"e42823","DOI":"10.1371\/journal.pone.0042823","article-title":"GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease","volume":"7","author":"Kamphuis","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.neulet.2014.11.013_bib0070","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2174\/156720512802455386","article-title":"Roles of glycogen synthase kinase 3 in Alzheimer\u2019s disease","volume":"9","author":"Cai","year":"2012","journal-title":"Curr. Alzheimer Res."},{"issue":"5","key":"10.1016\/j.neulet.2014.11.013_bib0075","first-page":"516","article-title":"GSK-3beta: a central kinase for neurodegenerative diseases?","volume":"26","author":"Petit-Paitel","year":"2010","journal-title":"Med. Sci."},{"issue":"2","key":"10.1016\/j.neulet.2014.11.013_bib0080","first-page":"562","article-title":"Deferoxamine: emerging, new neuro-protective benefits","volume":"34","author":"Kapoor","year":"2013","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.neulet.2014.11.013_bib0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/156720507779939832","article-title":"Glycogen synthase kinase-3 in neurodegeneration and neuroprotection: lessons from lithium","volume":"4","author":"Aghdam","year":"2007","journal-title":"Curr. Alzheimer Res."},{"issue":"17","key":"10.1016\/j.neulet.2014.11.013_bib0090","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1007\/s00018-007-7218-4","article-title":"Causes of oxidative stress in Alzheimer disease","volume":"64","author":"Zhu","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.neulet.2014.11.013_bib0095","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.numecd.2005.05.003","article-title":"A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress","volume":"15","author":"Del Rio","year":"2005","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"5","key":"10.1016\/j.neulet.2014.11.013_bib0100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1358\/mf.2003.25.5.769659","article-title":"Effects of deferoxamine on tissue lactate and malondialdehyde levels in cerebral ischemia","volume":"25","author":"Bariskaner","year":"2003","journal-title":"Methods Findings Exp. Clin. Pharmacol."},{"issue":"26","key":"10.1016\/j.neulet.2014.11.013_bib0105","doi-asserted-by":"crossref","first-page":"E1649","DOI":"10.1097\/BRS.0000000000000055","article-title":"Comparison of deferoxamine and methylprednisolone: protective effect of pharmacological agents on lipid peroxidation in spinal cord injury in rats","volume":"38","author":"Dinc","year":"2013","journal-title":"Spine (Phila Pa 1976)"},{"issue":"7","key":"10.1016\/j.neulet.2014.11.013_bib0110","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.neuint.2012.07.024","article-title":"Synergist effects of n-acetylcysteine and deferoxamine treatment on behavioral and oxidative parameters induced by chronic mild stress in rats","volume":"61","author":"Arent","year":"2012","journal-title":"Neurochem. Int."},{"issue":"8","key":"10.1016\/j.neulet.2014.11.013_bib0115","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.neuint.2010.03.025","article-title":"Long-chain 3-hydroxy fatty acids accumulating in LCHAD and MTP deficiencies induce oxidative stress in rat brain","volume":"56","author":"Tonin","year":"2010","journal-title":"Neurochem. Int."},{"issue":"2-3","key":"10.1016\/j.neulet.2014.11.013_bib0120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3233\/JAD-2006-102-315","article-title":"Aluminum and other metals in Alzheimer\u2019s disease: a review of potential therapy with chelating agents","volume":"10","author":"Domingo","year":"2006","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"2","key":"10.1016\/j.neulet.2014.11.013_bib0125","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.neurobiolaging.2012.05.009","article-title":"Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer\u2019s disease","volume":"34","author":"Guo","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.neulet.2014.11.013_bib0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/alzrt74","article-title":"Mitochondrial dysfunction \u2013 the beginning of the end in Alzheimer\u2019s disease? Separate and synergistic modes of tau and amyloid-beta toxicity","volume":"3","author":"Eckert","year":"2011","journal-title":"Alzheimer\u2019s Res. Ther."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394014008805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394014008805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T08:57:19Z","timestamp":1566032239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394014008805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":26,"alternative-id":["S0304394014008805"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2014.11.013","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP\/PS1 model of amyloid accumulation","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2014.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}